EuroGRAFT
Action number CA17138 COST

Welcome

Action number CA17138 will bring together Chronic GvHD (cGvHD) researchers across Europe for the first time, creating a network of cross-disciplinary experts in the field.

We aim to link research groups, clinical teams and industry partners throughout Europe to enable a breakthrough in scientific developments, leading to new concepts for improving the survival and quality of life of transplant patients.

Learn more

Introduction to the Action

The Action will lead to an improved understanding of the pathogenesis of cGvHD and its associated comorbidities, and will develop a coordinated approach to therapy, strengthening European research and innovation via collaboration.

 

Countries taking part

Please see map showing the geographical spread of EuroGraft participating countries. We welcome new countries to join us.

If you would like for your country to be involved in the Action,  please follow the link below to see how you can participate.

 

Get involved

United Kingdom

  • Dr Shaheda Ahmed

  • Dr Xiao-Nong Wang

  • Dr Rachel Crossland

  • Prof. Anne Dickinson

Germany

  • Prof Gabriele Multhoff

  • Ulrike Koehl

  • Robert Zeiser

  • Daniel Wolff

Italy

  • Prof Sara Galimberti

  • Atillio Olivieri

  • Prof Chiara Bonini

Poland

  • Prof Katarzyna Bogunia-Kubik

France

  • Dr Nuala Mooney

  • Prof Gerard Socie

Portugal

  • Dr Jose Silvestre Serra Da Silva

Croatia

  • Magdalena Grce

  • Drazen Pulanic

Austria

  • Dr Alexander Deutsch

  • Dr Anita Lawitschka

  • Prof. Hildegard Greinix

Belgium

  • Dr Philippe Lewalle

  • Dr Hélène Schoemans

Bosnia and Herzegovina

  • Mr Josip Petrovic

Bulgaria

  • Prof Milena Ivanova-Shivarova

  • Dr Maya Yordanova

Finland

  • Dr Satu Koskela

  • Prof Jukka Partanen

Hungary

  • Dr Miklós László Udvardy

  • Dr Hajnalka Andrikovics

Norway

  • Prof Frode Jahnsen

  • Prof Marit Inngjerdingen

  • Prof Lisbet Sviland

Serbia

  • Dr Emina Milosevic

  • Dr Vladimir Perovic

Spain

  • Dr Anna Barata

  • Antonio Pérez Martínez

Switzerland

  • Dr Jörg Halter

Estonia

  • Dr Eric Tkaczyk

 

Meet our working groups

Epidemiology

The development of an epidemiological platform on cGvHD within EUROGRAFT is a novel approach tounderstanding the disease incidence and associated comorbidities. Results of the analysis will enablea deeper understanding of the incidence of the disease and enable additional data to be included in current European wide databases for use in future clinical trials.

Biomarkers

This Working Group will assess the type and amount of biomarker information which is currently available in the literature and assess those which are worthy of further validation and study.

Socioeconomics/Quality of life

CGvHD is a long term complex disease which has several co-morbidities and as such impacts on the quality of life of patients. By studying the societal impact of the disease via documented quality of life assessments, including reduced working days due to hospital stays, EUROGRAFT will allow an improved assessment of the burden on society of cGvHD at both the individual and European level.

NIH Consensus

The NIH consensus criteria needs to be implemented uniformly if diagnosis and treatment of
cGVHD is to be optimized. The aim of this Working Group will be to aid in both the understanding and
implementation of the NIH Consensus via Training Schools and workshops.

Immunotherapy

Patients with cGvHD (30-50%) can become refractory to standard therapy, new treatment options and the assessment of current novel therapies are urgently needed to improve the long term outcome and quality of life. In this Working Group the Action will bring together experts in cGVHD and clinical trial development, especially in the realm of cellular therapies with the aim of developing concepts for new approaches including personalized approaches to therapy.

Are you interested
in taking part?

The COST Action EUROGRAFT welcomes research-active scientists working in the field. There are many ways to get involved.

Get involved

Get involved

Do you have a question?

If you have any questions or would like to know more about the project, simply connect with us and we’ll be happy to talk to you.